63E.SG - Onward Medical N.V.
| Previous close | 6.02 |
| Open | 6.06 |
| Bid | 6.04 x N/A |
| Ask | 6.36 x N/A |
| Day's range | 6.06 - 6.06 |
| 52-week range | 4.28 - 6.40 |
| Volume | |
| Avg. volume | 177 |
| Market cap | 182.916M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.13 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
GlobeNewswireBrain Computer Interface (BCI) Enables Thought-Controlled Walking after Spinal Cord Injury
Pioneering study in Nature demonstrates that adding a BCI to ONWARD® ARC Therapy™ can enable thought-controlled standing, walking, and stair climbingEINDHOVEN, the Netherlands, May 24, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today announces a publication in Nature showing that a wireless brain-computer
- GlobeNewswire
ONWARD Reports Q1 Business Update and Year-To-Date Highlights
First-in-Human Use of the ARC-IM™ LeadNew Breakthrough Device Designation Awarded by the U.S. FDA for ARC Therapy™, Bringing Total to 9 10 Additional Patents Issued, Bringing Total Pending and Issued Patents to More than 340 and Strengthening First-Mover Advantage EINDHOVEN, the Netherlands, May 16, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, function, and independence in people with spinal cord
- GlobeNewswire
ONWARD Announces First-in-Human Use of ARC-IM™ Lead to Restore Movement and Function after Spinal Cord Injury
New lead is purpose-designed to optimize the delivery of ONWARD ARC Therapy™EINDHOVEN, the Netherlands, May 15, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today announced the successful first-in-human use of its investigational ARC-IM Lead. The ARC-IM Lead delivers targeted electrical pulses to the spinal cord and is a key compo
- GlobeNewswire
ONWARD Announces Results of Annual General Meeting of Shareholders
Shareholders approve all proposed resolutionsEINDHOVEN, the Netherlands, May 08, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies for people with spinal cord injury, today announces all proposed resolutions at its Annual General Meeting of Shareholders (AGM) were duly passed. The meeting was held this afternoon in Amsterdam, the Netherlands at 2.00 p.m. CET. Full details of the resolutions approved during the AGM can be f
- GlobeNewswire
ONWARD Schedules Webcast to Provide First Quarter Business Update
EINDHOVEN, the Netherlands, LAUSANNE, Switzerland, and BOSTON, MA, USA, May 03, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore mobility, function, and independence in people with spinal cord injury, today announced that it will host a webcast to discuss its Q1 2023 business highlights. The webcast will be held on May 16, 2023, at 2:00PM CET / 08:00AM ET. It will be hosted by CEO Dave Marver and CFO Lara Smith
- GlobeNewswire
ONWARD to Attend Upcoming Scientific and Investor Events
EINDHOVEN, the Netherlands, LAUSANNE, Switzerland, and BOSTON, MA USA, April 12, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury (SCI), today announced that management will attend the following conferences in the upcoming weeks: ASIA 50th Annual Scientific Meeting (American Spinal Injury Association)April 17-19, 2023Atlanta, GA, USDave Marver
- GlobeNewswire
ONWARD Publishes First Annual ESG Summary
EINDHOVEN, the Netherlands, LAUSANNE, Switzerland, and BOSTON, MA USA, March 30, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today publishes its first Annual ESG Summary. The summary is available here and on the Company’s website in the Investors section (www.ir.onwd.com/esg-information). “ONWARD is committed to creating long-term value
- GlobeNewswire
Convocation of the 2023 Annual General Meeting of Shareholders and Proposed Resolutions
THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014). EINDHOVEN, Pays-Bas et LAUSANNE, Suisse, et BOSTON, MA, Etats-Unis, March 27, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD) (the Company), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today has convened the 2023 Annual General Meeting of Shareholders (A
- GlobeNewswire
ONWARD Reports 2022 Full Year Financial and Operating Results
Company also Provides Business Update and Outlook for 2023 - Conference Call and Webcast (in English) March 28, 2023, at 2:00 PM CEST/8:00 AM EDTTHIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) EINDHOVEN, the Netherlands, LAUSANNE, Switzerland & BOSTON, MA USA, March 27, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement,
- GlobeNewswire
ONWARD to Publish Full Year 2022 Financial Results and Host Webcast on March 28, 2023
EINDHOVEN, the Netherlands, LAUSANNE, Switzerland, and BOSTON, MA USA, March 14, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announced it will publish full year 2022 financial and operating results on Tuesday, March 28, 2023. Management will also host a webcast to discuss operational and financial highlights, as well as provide a b
- GlobeNewswire
ONWARD Does Not Hold Cash Deposits at Silicon Valley Bank
The company’s cash is held at banks with a Moody’s rating of A1 or higherEINDHOVEN, the Netherlands, LAUSANNE, Switzerland, and BOSTON, MA USA, March 13, 2023 (GLOBE NEWSWIRE) -- March 13, 2023 – ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announced it does not hold cash deposits nor securities at Silicon Valley Bank (SVB). On March 10, 2023, the Californi
- GlobeNewswire
ONWARD Receives New FDA Breakthrough Device Designations for Bladder Control, Alleviation of Spasticity, and Blood Pressure Regulation after Spinal Cord Injury
The company has now been awarded a total of eight FDA Breakthrough Device Designations for its innovative SCI therapiesEINDHOVEN, the Netherlands, LAUSANNE, Switzerland, and BOSTON, MA USA, Feb. 23, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury (SCI), today announced it has been granted Breakthrough Device Designation status from the U.S. F
- GlobeNewswire
ONWARD Strengthens Leadership Team with Key Appointments in Clinical & Regulatory and Marketing
Erika Ross to join the company as VP Global Clinical & Regulatory, and Sarah Moore to join as VP Global MarketingEINDHOVEN, the Netherlands, LAUSANNE, Switzerland, and BOSTON, MA USA, Jan. 23, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury (SCI), today announced two key appointments to its leadership team to drive the Company’s clinical rese
- GlobeNewswire
ONWARD Announces Participation at Upcoming Events
EINDHOVEN, the Netherlands, LAUSANNE, Switzerland, and BOSTON, MA USA, Jan. 16, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announced that management will participate in the following events in the upcoming weeks: Degroof Petercam Healthcare ConferenceJanuary 26, 2023Brussels, BelgiumDave Marver, CEO, will participate in 1:1 meetin
Business WireONWARD Reports Interim Clinical Outcomes for Implantable ARC Therapy Demonstrating Potential to Improve Blood Pressure Regulation after Spinal Cord Injury
EINDHOVEN, the Netherlands & LAUSANNE, Switzerland, & BOSTON, December 08, 2022--ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury (SCI), today reported interim clinical outcomes from the first ten1 people treated to regulate blood pressure with implantable ARC Therapy, ONWARD’s targeted spinal cord stimulation technique. ARC Therapy immediately improved blood pressure
Business WireONWARD Awarded European Innovation Council Grant to Further Develop Brain-Computer Interface Technology; Company also Wins First Place in 2022 Brain-Computer Interface Awards
EINDHOVEN, the Netherlands & LAUSANNE, Switzerland & BOSTON, Mass., November 21, 2022--ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury (SCI), today announced that the Company has been awarded a second grant from the European Innovation Council (EIC) to support the enhancement of an innovative Brain-Computer Interface (BCI) technology for restoring mobility and upper
Business WireONWARD’s Research Partner .NeuroRestore Publishes Groundbreaking Paper Identifying Neurons that Restore Walking after Paralysis
EINDHOVEN, the Netherlands & LAUSANNE, Switzerland & BOSTON, November 10, 2022--ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury (SCI), today reported that a new study by scientists at .NeuroRestore, ONWARD’s research partner, has identified the specific neurons that are activated and remodeled by spinal cord stimulation, enabling individuals with spinal cord injury t
Business WireONWARD Reports Third Quarter 2022 Highlights and Provides Business Update
EINDHOVEN, the Netherlands & LAUSANNE, Switzerland & BOSTON, November 08, 2022-- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury (SCI), today discussed highlights from the third quarter of 2022 and provided a business update.
Business WireONWARD Schedules Webcast to Provide Third Quarter Business Update and Announces Participation at Upcoming Conferences
EINDHOVEN, the Netherlands & LAUSANNE, Switzerland & BOSTON, October 27, 2022--ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announced that it will host a webcast to discuss its Q3 business highlights. The Company also provided information on its participation at upcoming investor and industry events.
Business WireONWARD Announces Topline Results from the LIFT Home Study Supporting Safety and Feasibility of ARC-EX Therapy to Treat People with Spinal Cord Injury at Home
EINDHOVEN, the Netherlands & LAUSANNE, Switzerland & BOSTON, October 05, 2022--ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury (SCI), today reported topline results from the LIFT Home study, evaluating the safety and feasibility of ARC-EX Therapy when used at home. ARC-EX Therapy is a proprietary non-invasive spinal cord stimulation technology designed to restore mov
Business WireONWARD Announces Participation at Upcoming Events in October
EINDHOVEN, the Netherlands & LAUSANNE, Switzerland & BOSTON, September 29, 2022--ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announced that management will participate in the following upcoming events in October:
Business WireONWARD Reports Positive Topline Results from a Pivotal Study to Restore Arm and Hand Function in People With Spinal Cord Injury
EINDHOVEN, the Netherlands & LAUSANNE, Switzerland & BOSTON, September 13, 2022--ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury (SCI), today announced that the Up-LIFT pivotal study evaluating ARC-EX Therapy achieved its primary effectiveness endpoint of improvement in upper extremity strength and function. ARC-EX Therapy is a proprietary non-invasive spinal cord st
Business WireSpinal Cord Stimulation Delivers Improved Arm Function
EINDHOVEN, the Netherlands & LAUSANNE, Switzerland, June 30, 2022--ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announces a Nature Neuroscience publication showing the potential for ONWARD’s ARCIM Therapy to restore movement and function in hands and arms after spinal cord injury.
Business WireONWARD Awarded European Innovation Council Grant to Develop Brain-Spine Interface Technology
EINDHOVEN, the Netherlands & LAUSANNE, Switzerland, June 16, 2022--ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury (SCI), today announces it has been awarded a grant from the European Innovation Council (EIC) to support the development of an innovative Brain-Spine Interface technology for restoring mobility and upper limb function.
Business WireONWARD Announces New Board Appointment
EINDHOVEN, the Netherlands & LAUSANNE, Switzerland, June 13, 2022--ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announces the appointment of Kristina Dziekan to its Board of Directors.